ResourcesArticles in support of Corsano’s scientific approach.
Out-of-hospital cardiac arrest (OHCA) is a leading cause of global mortality. Delays to initiation of cardiopulmonary resuscitation (CPR) should be as short as possible to achieve the highest survival chance.
Wearables have the potential to monitor patients remotely. The Corsano CardioWatch 287-2 is such a medical device that can monitor atrial fibrillation and long-term blood pressure.
MULTI-VITAL Multi Parameter Vital Signs Monitoring by the Corsano Cardiowatch 287-2 Validation Study
Investigating the potential of Corsano Cardiowatch 287 monitoring bracelet in monitoring patients with Chronic Obstructive Pulmonary Disease (COPD) at high risk of exacerbations
An observational study in patients between 12 and 70 years old with an acute asthma exacerbation, to determine the relation between phenotypical characteristics and the treatment response.
Evaluation of the performance and efficacy of the Corsano Cardiowatch 287 Bracelet in measuring respiratory rate at rest, as compared to golden standard and predicate device.
Safety and efficacy of anti-CD19 CAR T in subjects with Chronic Lymphocytic Leukemia or Small Lymphocytic L...
A phase I/II, multicenter study evaluating the feasibility, safety, and efficacy of point-of-care manufactured 19CP02 in subjects with relapsed/refractory B-cell non-Hodgkin lymphoma.
The present study is looking for calibration and accuracy of SpO2, Pulse Rate and Respiration Rate derived by a newly developed based wrist device (CardioWatch 287-2 or Test Device).
The first 1000 days of life reflect the period from the 3 months before conception until the age of 2 years. An accumulating body of evidence suggest that social-demographic background
To study the feasibility, efficacy and performance of the Corsano CardioWatch 287 module with a photoplethysmographic sensor for measuring heart rate and RR-intervals
Vital sign changes often precede cardiac arrest, unexpected death, or ICU admission. If observed and treated, it could prevent the patient’s condition from deteriorating.
Obesity is a global epidemic. Obesity is associated with an increased risk of atrial fibrillation (AF). AF is the most common sustained cardiac rhythm disorder in humans with potentially life threatening complications.
Atrial fibrillation (AF) is the most common cardiac arrhythmia and a major risk factor for cerebrovascular insults. Screening for AF in hospitalized patients is challenging. The classical ECG monitoring requires
The number of cardiac patients with obesity is rising, however their number of referral to cardiac rehabilitation (CR) is not. Patients with obesity report a higher level of anxiety, a greater fear of movement after a cardiac event
In this study, we try to investigate the impact of air quality and green-blue spaces on vital signs, stress, and mood states. Using a scripted exposure protocol subjects will perform aerobic exercises
The first 1000 days of life reflect the period from the 3 months before conception until the age of 2 years. An accumulating body of evidence suggest that social-demographic background, lifestyle and nutrition of both parents during
Determine AF Burden With PPG Trial – Detection and Quantification of Episodes of Atrial Fibrillation
In this prospective single-center trial, a wearable photoplethysmographic (PPG) sensor coupled with a cloud analytics service will be used to detect and quantify atrial fibrillation (AF) episodes in patients with known paroxysmal AF.
Corsano EndoWatch: The smart wearable that helps to improve life of patients after treatment of a suprasell...
Patients with a suprasellar (hypothalamic) brain tumour often have excellent survival, but poor outcome due to hypothalamic dysfunction (HD). The hypothalamus is an endocrine gland and the key-regulator of our body.
Bone metastases represent a common complication in cancer patients, particularly in advanced stages of the disease. The presence of bone metastases can cause skeletal-related events, such as bone pain, pathological fractures